✦ LIBER ✦

Phase I and pharmacologic study of the macromolecular topoisomerase-I-inhibitor DE-310 given once every 2 or 6 weeks in patients with solid tumors

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacokinetic study of D

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

38 POSTER Phase I and pharmacological st

✍ F.A.L.M. Eskens; M.J.A. de Jonge; L. van Doorn; T. Isoe; K. Hayashi; S. Hussain; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

396 A Phase I, Dose-finding Study of BI

✍ de Jonge, M.; Sahebjam, S.; Mathijssen, R.H.; Razak, A.; van der Biessen, D.; Pr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A phase I pharmacokinetic (PK) and seria

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB